Signal: Sanofi becomes latest pharma giant to spin off consumer healthcare business
French pharmaceuticals giant Sanofi announced today (27 October) that it intends to spin out its consumer healthcare division, initially created…
Sanofi
-
-
Sanofi agrees on monetary settlement for bribery charges
Sanofi has agreed on a civil settlement with the US Securities and Exchange Commission (SEC) to resolve charges related to…
-
Sanofi’s Cablivi receives EC approval to treat rare blood disorder
The European Commission (EC) has granted marketing authorisation for Sanofi’s Cablivi (caplacizumab) indicated to treat adults with acquired thrombotic thrombocytopenic…
-
Sanofi and Revolution Medicines partner to develop cancer treatments
Sanofi has formed an alliance with US-based drug discovery company Revolution Medicines to develop and commercialise potential treatments for non-small…
-
Sanofi integrates infectious disease unit into Evotec
Sanofi has completed the strategic integration of its infectious disease unit, including most of the associated research portfolio, into German…
